Ինդոնեզիա - ինդոնեզերեն - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

aventis pharma - indonesia - insulin glargine, lixisenatide - larutan injeksi - 100 iu/ml /50 mcg/ml

Ինդոնեզիա - ինդոնեզերեն - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

aventis pharma - indonesia - amiodarone - tablet - 200 mg

Ինդոնեզիա - ինդոնեզերեն - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

aventis pharma - indonesia - amiodarone hydrochloride - tablet - 200 mg

Ինդոնեզիա - ինդոնեզերեն - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

aventis pharma - indonesia - metronidazole - infus - 5 mg/ml

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sodium cromoglicate 5mg equivalent to 3.5211% w/w;  ;   - aerosol inhaler, metered dose - 5 mg/dose - active: sodium cromoglicate 5mg equivalent to 3.5211% w/w     excipient: apaflurane macrogol 600 povidone - intal forte 5 mg cfc-free is indicated for the preventive treatment of bronchial asthma (which may be due to allergy, exercise, cold air or chemical irritants) in adults and children.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - nedocromil sodium 1.4085%{relative} (2 mg/dose);   - aerosol inhaler, metered dose - 2 mg/dose - active: nedocromil sodium 1.4085%{relative} (2 mg/dose)   excipient: apaflurane macrogol 600 menthol povidone - tilade cfc-free is indicated in the treatment of bronchial asthma (whether extrinsic or intrinsic in nature, and including asthmatic bronchitis, late onset asthma, exercise induced asthma, and bronchospasm provoked by a variety of stimuli such as cold air, inhaled allergens, atmospheric pollutants and other irritants). tilade cfc-free is intended for regular prophylactic treatment and not for symptomatic relief. in the management of asthma, tilade cfc-free improves pulmonary function, reduces the frequency and severity of attacks and reduces bronchospasm, cough and bronchial hyper-responsiveness. in patients already receiving treatment for their asthma, tilade cfc-free can be given in addition to all existing therapies and will in many cases provide added therapeutic benefit. having established this benefit of tilade cfc-free, it may be possible to gradually reduce or eliminate concomitant therapy.

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - docetaxel trihydrate 21.34mg/ml eqv docetaxel - infusion, solution concentrate - 20mg/ml - docetaxel trihydrate 21.34mg/ml eqv docetaxel 20mg/ml

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - docetaxel trihydrate 85.36mg/4ml eqv docetaxel - infusion, solution concentrate - 80mg/4ml - docetaxel trihydrate 85.36mg/4ml eqv docetaxel 80mg/4ml

Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aventis pharma - marea britanie - oxaliplatinum - conc. pt. sol. perf. - 5mg/ml - alte antineoplazice compusi de platina

Վենեսուելա - իսպաներեն - Instituto Nacional de Higiene

sanofi-aventis de venezuela s.a. - metamizol sÓdico - solucion inyectable - 1g / 2ml